I-MAB is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative biologics for the treatment of cancer and autoimmune diseases. With a strong pipeline and strategic partnerships, the company is well-positioned for growth in the rapidly expanding healthcare sector.
